INTIMATION FOR THE APPOINTMENT OF ADDITIONAL DIRECTOR
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has informed the stock exchanges about the appointment of an Additional Director on its board. This is a routine corporate intimation made in compliance with listing requirements. The company has not disclosed the name, background, or specific role of the appointee in the headline. No resignation or governance concerns are mentioned in this filing.
This is a standard board-level change announcement with no immediate material impact on shareholders or the stock price. Investors may want to look for further details on the new director's identity and role to assess any strategic implications.